Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

AC Immune (ACIU) Leases (2016 - 2025)

AC Immune has reported Leases over the past 9 years, most recently at $5.7 million for Q4 2025.

  • Quarterly Leases fell 8.48% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, down 8.48% year-over-year, with the annual reading at $5.7 million for FY2025, 8.48% down from the prior year.
  • Leases was $5.7 million for Q4 2025 at AC Immune, down from $5.8 million in the prior quarter.
  • Over five years, Leases peaked at $4.0 billion in Q4 2023 and troughed at $2.6 million in Q3 2022.
  • The 5-year median for Leases is $4.8 million (2025), against an average of $765.5 million.
  • Year-over-year, Leases soared 139704.44% in 2021 and then crashed 99.91% in 2022.
  • A 5-year view of Leases shows it stood at $3.2 billion in 2021, then tumbled by 99.91% to $2.9 million in 2022, then surged by 135580.19% to $4.0 billion in 2023, then crashed by 99.84% to $6.2 million in 2024, then decreased by 8.48% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Leases are $5.7 million (Q4 2025), $5.8 million (Q3 2025), and $6.0 million (Q2 2025).